Posted on June 28, 20246/28/24
European Parliament’s Revision of the General Pharmaceutical Legislation
Posted on June 24, 20246/24/24
Market Access and the Inflation Reduction Act
Posted on May 13, 20245/13/24
Price Right or Pay Later
Posted on April 10, 20244/10/24
Understanding ICER’s 2024 Protocol for Assessing Unsupported Price Increases on Prescription Drugs
Posted on June 20, 20236/20/23
Key Considerations When Operationalizing Revenue Management
Posted on June 12, 20236/12/23
Informing Optimal Pricing Strategies with a Comprehensive Modeling Approach
Posted on May 25, 20235/25/23
The Influx of Generic Launches Leaves Narrow Opportunities for Multiple Sclerosis Access
Posted on May 21, 20235/21/23
Pricing Complexities of a Combination Therapy
Posted on May 17, 20235/17/23